Browsing by Author "Brunet i Vidal, Joan"
​ ​ scopusId Brunet i Vidal, Joan​ ​

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)

Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling

Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models

EXiT CBR: A framework for case-based medical diagnosis development and experimentation

Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment

Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis

Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin

Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer

Ethics competences in the undergraduate medical education curriculum: The Spanish experience

BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells

Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer

Shared heritability and functional enrichment across six solid cancers

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

Germline variation in O6-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer

NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas

Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?

Highly sensitive MLH1 methylation analysis in blood identifies a cancer patient with low-level mosaic MLH1 epimutation

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors